159 related articles for article (PubMed ID: 10457335)
21. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin.
Ji B; Bi Y; Simeone D; Mortensen RM; Logsdon CD
Gastroenterology; 2001 Dec; 121(6):1380-90. PubMed ID: 11729117
[TBL] [Abstract][Full Text] [Related]
22. Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence.
Watson SA; Morris TM; McWilliams DF; Harris J; Evans S; Smith A; Clarke PA
Br J Cancer; 2002 Aug; 87(5):567-73. PubMed ID: 12189558
[TBL] [Abstract][Full Text] [Related]
23. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
[TBL] [Abstract][Full Text] [Related]
24. Expression of receptors for gut peptides in pancreata of BOP-treated and control hamsters.
Tang C; Biemond I; Appel MJ; Visser CJ; Woutersen RA; Lamers CB
Carcinogenesis; 1996 Oct; 17(10):2171-5. PubMed ID: 8895485
[TBL] [Abstract][Full Text] [Related]
25. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors.
Singh P; Owlia A; Espeijo R; Dai B
J Biol Chem; 1995 Apr; 270(15):8429-38. PubMed ID: 7721737
[TBL] [Abstract][Full Text] [Related]
26. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
Argani P; Iacobuzio-Donahue C; Ryu B; Rosty C; Goggins M; Wilentz RE; Murugesan SR; Leach SD; Jaffee E; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Clin Cancer Res; 2001 Dec; 7(12):3862-8. PubMed ID: 11751476
[TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin and pancreatic cancer: the chicken or the egg?
Smith JP; Solomon TE
Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(2):G91-G101. PubMed ID: 24177032
[TBL] [Abstract][Full Text] [Related]
28. Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Pancreas; 1993 Sep; 8(5):615-21. PubMed ID: 8302799
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin receptors and PANC-1 human pancreatic cancer cells.
Smith JP; Rickabaugh CA; McLaughlin PJ; Zagon IS
Am J Physiol; 1993 Jul; 265(1 Pt 1):G149-55. PubMed ID: 8338163
[TBL] [Abstract][Full Text] [Related]
30. Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines.
Jang JY; Kim SW; Ku JL; Park YH; Park JG
World J Gastroenterol; 2005 Feb; 11(6):803-9. PubMed ID: 15682471
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin.
Kano M; Shoda J; Satoh S; Kobayashi M; Matsuzaki Y; Abei M; Tanaka N
J Lab Clin Med; 2002 May; 139(5):285-94. PubMed ID: 12032489
[TBL] [Abstract][Full Text] [Related]
32. Human pancreatic cancer cell lines express the CCKB receptor.
de Weerth A; von Schrenck T; Löhr M; Mirau S; Greten H; Kalthoff H
Hepatogastroenterology; 1999; 46(25):472-8. PubMed ID: 10228846
[TBL] [Abstract][Full Text] [Related]
33. Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor.
Nadella S; Burks J; Al-Sabban A; Inyang G; Wang J; Tucker RD; Zamanis ME; Bukowski W; Shivapurkar N; Smith JP
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G699-G712. PubMed ID: 29927319
[TBL] [Abstract][Full Text] [Related]
34. Guinea pig gallbladder and pancreas possess identical CCK-A receptor subtypes: receptor cloning and expression.
De Weerth A; Pisegna JR; Wank SA
Am J Physiol; 1993 Dec; 265(6 Pt 1):G1116-21. PubMed ID: 7916580
[TBL] [Abstract][Full Text] [Related]
35. Defects of cholecystokinin (CCK)-A receptor gene expression and CCK-A receptor-mediated biological functions in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Nakamura H; Kihara Y; Tashiro M; Kanagawa K; Shirohara H; Yamamoto M; Yoshikawa H; Fukumitsu K; Hirohata Y; Otsuki M
J Gastroenterol; 1998 Oct; 33(5):702-9. PubMed ID: 9773935
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic CCK(B) receptors: their potential roles in somatostatin release and delta-cell proliferation.
Morisset J; Wong H; Walsh JH; Lainé J; Bourassa J
Am J Physiol Gastrointest Liver Physiol; 2000 Jul; 279(1):G148-56. PubMed ID: 10898757
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
38. Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer.
Ketterer K; Rao S; Friess H; Weiss J; Büchler MW; Korc M
Clin Cancer Res; 2003 Nov; 9(14):5127-36. PubMed ID: 14613990
[TBL] [Abstract][Full Text] [Related]
39. The method of administration of cholecystokinin determines the effects evoked in the pancreas.
Ohlsson B; Borg K; Rehfeld JF; Axelson J; Sundler F
Pancreas; 2001 Jul; 23(1):94-101. PubMed ID: 11451154
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic endocrine dysfunction in rats not expressing the cholecystokinin-A receptor.
Funakoshi A; Miyasaka K; Kanai S; Masuda M; Yasunami Y; Nagai T; Ikeda S; Jimi A; Kawanami T; Kono A
Pancreas; 1996 Apr; 12(3):230-6. PubMed ID: 8830328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
